Post-mortem genetic testing used to find underlying cause of sudden deaths in Amish families

Researchers used post-mortem genetic testing to find the underlying cause of multiple sudden deaths in young people and sudden cardiac arrests in two large Amish families.

Using an exome molecular autopsy, Michael Ackerman, M.D., Ph.D., and his associates conducted genetic testing of four siblings who each died suddenly during exercise. Dr. Ackerman is a genetic cardiologist and director of the Windland Smith Rice Comprehensive Sudden Cardiac Death Program at Mayo Clinic. The findings are published in JAMA Cardiology. Dr. Ackerman is the senior author.

Based on a family history of exercise-associated sudden deaths in the young and sudden cardiac arrests, researchers suspected a recessive inheritance pattern because the parents of affected children did not show visible characteristics, or phenotype. This recessive condition requires the inheritance of the genetic variant from each parent, such that the children who are affected have two copies of the variant. If both parents carry a single copy of the genetic variant, their children have a 25% chance of inheriting two copies of the variant and are likely to express the phenotype that puts them at risk for sudden cardiac arrest or sudden death.

Alarmingly, people with this condition often have an unremarkable clinical course and routine cardiology clinical testing, such as an electrocardiogram or even stress testing, that do not reveal an individual at risk for a sudden cardiac event."

Dr. Michael Ackerman, genetic cardiologist and director of the Windland Smith Rice Comprehensive Sudden Cardiac Death Program at Mayo Clinic

A molecular autopsy revealed a common genetic factor among all four siblings. Each had the same homozygous multiexon duplication in RYR2, as did multiple distantly related relatives who also experienced a sudden cardiac arrest during exercise. Researchers then compared a second, unrelated Amish family that also has multiple exertion-related sudden deaths and sudden cardiac arrests in the young. Genetic testing confirmed that both families possessed the exact same gene duplication. To date, 23 family members have been identified as being affected. Of those 23 family members, 18 have tragically died suddenly at a young age.

Identifying which people in these Amish communities are at risk is important for their future, but it is difficult without genetic testing.

"Now that our genetic sleuthing has revealed the underlying genetic cause for these families' tragic events, a simple genetic test can be performed to identify family members at risk for their own sudden cardiac arrest," Dr. Ackerman says. "In fact, identification of unaffected heterozygous carriers may provide potentially lifesaving premarital counseling and reproductive planning for the Amish community."

The researchers are re-engineering blood samples into beating heart cells from two affected people to create a "disease-in-the-dish" cellular model. This effort will provide further insights into the molecular and cellular mechanisms that are causing these tragedies, according to David Tester, first author of the study and lead scientist for the Windland Smith Rice Sudden Death Genomics Laboratory at Mayo Clinic.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Leveraging genetic variations for more effective cancer therapies